Description
Indication & Scope
KuiHua® HuGanPian soothes liver‑qi, invigorates spleen‑digestion, reduces transaminase level. For chronic hepatitis and early liver cirrhosis.
- Mechanism: Composite herbal components produce hepatoprotective effect, alleviate liver inflammatory injury and assist reduction of elevated transaminase.
- Drug class: Chinese patent medicine for liver protection.
- Clinical use: Adjuvant therapy for chronic hepatic injury, chronic hepatitis and early‑stage liver cirrhosis.
| Generic Name | HuGanPian |
| Brand Name | KuiHua®; HongLvDeng® |
| Ingredient | Chaihu, Yinchen, Banlangen, Schisandra chinensis, Pig bile powder, Green beans |
| Dosage Form | Tablets |
| Package | KuiHua:
0.35g*100 tablets/box; 0.35g*48 tablets/box; 0.35g*120 tablets/box; 0.35g*200 tablets/box; 0.35g*100 tablets*4 bottles/box HongLvDeng: |
| Conditions Treated | Chronic hepatitis, early liver cirrhosis with liver‑qi stagnation and spleen‑deficiency pattern |
| Taboos | Hypersensitivity to any ingredient of this preparation is contraindication. Not sole substitution for etiological treatment of viral hepatitis |
| Place of origin | China |
| Prescription type | Prescription‑only |
| Storage Conditions | Seal well and store in dry cool environment, avoid dampness |
| Manufacturer | Heilongjiang Sunflower Pharmaceutical Co., Ltd.; Tonghua Aixin Pharmaceutical Co., Ltd. |
| Registration Authority | National Medical Products Administration (NMPA), China |
| Approval number | Z20003336; Z22023408 |
| Approval Date | Jun 4, 2025; May 26, 2025 |
| Shelf Life | 36 months |
How to use ?
Recommended Dose: 4 tablets per single administration.
Time: Three times each day.
Instructions for use: Oral administration with warm water. Avoid alcohol, greasy heavy food during medication.
Interaction: Simultaneous taking of other hepatoprotective agents needs medical evaluation. Limited specific interaction data from clinical research.
Side effects: Occasional mild gastrointestinal upset including abdominal distension and poor appetite; rare allergic skin reactions.
Important Notice
This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indicatiaon, and regional regulatory requirements.
Packaging & Shipping
Packaging
Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.
Shipping Methods
Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.
Export Support
Certificate of Analysis
GMP Certificate
Commercial Invoice
Packing List & CPP
Cold Chain Logistics
Customs Documentation
Scientific and regulatory sources
FAQ
What kind of liver‑related problems apply for HuGanPian intervention?
It acts as adjuvant measure for chronic hepatitis and early liver cirrhosis and helps lower raised transaminase value.
Can HuGanPian replace antiviral therapy for viral hepatitis?
This product serves hepatoprotective adjuvant purpose and cannot substitute specific etiological antiviral treatment.
What dietary restriction should be followed during HuGanPian administration?
Alcohol and heavy greasy food need avoidance to reduce additional liver burden.
Is long‑term continuous use of HuGanPian permitted without professional assessment?
Long‑term medication requires regular liver function monitoring under medical guidance.
KuiHua® | HuGanPian | Chronic Hepatitis/Early Cirrhosis | DengYueRX
INN: HuGanPian
Indications: Chronic hepatitis, early cirrhosis
Dosage Form: Tablets
Strength: 0.35g/tablet
Price range: $1.41 through $5.57
Low MOQ
WHO-GMP
Worldwide Delivery
Compliance and Regulatory Documents
Related Products
